Copy to clipboard 
Enovis closed the acquisition of LimaCorporate, a privately held global orthopedic device company focused on restoring motion through its portfolio of implant solutions.
Lima strengthens Enovis’ position in the global orthopedic reconstruction market with a complementary portfolio of surgical solutions and technologies, which will accelerate global growth and margin expansion. In addition, Lima’s portfolio includes 3D-printed Trabecular Titanium implants and a comprehensive revision offering in shoulders, which will further strengthen Enovis’ position in the extremities market.
“We are excited to welcome Lima’s talented team to Enovis. The combination brings Enovis’ recon segment to $1 billion in revenues and creates a fast-growing innovator in the global orthopedic reconstruction market. This is another great example of how we use strategic acquisitions to accelerate our growth, add great technologies and talent to our company, and drive compounding value for our shareholders,” said Matt Trerotola, Chair and Chief Executive Officer of Enovis.
Source: Enovis Corporation
